Bayer flags major Phase III results for stroke prevention drug asundexian
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
Collaboration integrates AJICAP™ technology with global manufacturing capabilities to streamline antibody-drug conjugate pipelines
One Health-based surveillance model to focus on bird sanctuaries and high-risk human populations
4th World Homoeopathy Summit at Palace of Westminster and University of Oxford spotlights integrative healthcare and global collaboration
The company reported net revenue of SEK 13.5 million for the full year 2025
The national platform brought together healthcare professionals, patient advocates, and stakeholders
he innovation could pave the way for early and low-cost screening of smoking exposure and second-hand smoke biomarkers
The upgrade centres on new machinery and advanced technology designed to expand capacity and sharpen turnaround times in increasingly competitive flexible packaging markets.
The grant backed by Novartis to strengthen academia-industry collaboration across all seven NIPERs
Outlines nine priority health tracks spanning TB research, digital health, early warning systems and regulatory cooperation
Subscribe To Our Newsletter & Stay Updated